Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical
Xinxiang, Henan, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical has approved drugs (Qi Shen Capsules for angina pectoris and sulfadiazine zinc for burns) on the Chinese market, with all programs at the commercial or approved stage, focusing on herbal medicine and small molecule drugs.[5]
- Therapeutic areas
- DermatologyCardiovascular
- Modalities
- Herbal medicineSmall molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical.